Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission
Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet.
Other Textiles📍 Nutley, NJFounded 2011
Current Valuation
$571.74M
as of 2019-Q3
PRIVATE
QL Price
$571.74M
0% vs last round
QuantLogix's current estimate for Modern Meadow, published 2026-09-27 — in line with the last disclosed round of $571.74M (2019-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$571.74M
2019-Q3
weight 0.01
Secondary market print
$571.74M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Modern Meadow since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Modern Meadow, 2026-09-27 (73e0170c4828ac57).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Modern Meadow going public?
No. Modern Meadow is private and has not filed to go public. There is no S-1 on file.
What is Modern Meadow's valuation in 2026?
Modern Meadow is valued at $571.74M as of 2019-Q3, set by its Series C ($151.74M, Sep 2019). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Modern Meadow filed an S-1?
No public S-1 is on file for Modern Meadow.
How much has Modern Meadow raised?
Modern Meadow has raised $205.29M in total, most recently a Series C of $151.74M in Sep 2019.
Is Modern Meadow publicly traded — can you buy Modern Meadow stock?
No. Modern Meadow is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Modern Meadow on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2011
HQ
Nutley, NJ
Employees
67
Total Raised
$205.29M
Last Round
Series C — $151.74M (Sep 2019)
IPO Status
private
Fundraising Status
Series C · $151.74M · 7y ago
privateTotal raised $205.29M
Secondary Market
Implied price / share
$12.88
Last round price / share
$12.88
vs last round
0.0%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$151.74M
Sep 2019
—
$571.74M
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Modern Meadow — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-27. Re-checked weekly.
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
3
via ashby
Product-build share
100%
engineering, research, product, design
Trajectory
steady
heavy product build — 100% of open roles are product-building functions (engineering/research/product) — 1 of 3 open roles are engineering.
Counted from Modern Meadow's live job board as of 2026-09-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2019-Q3. Refreshed quarterly.